China, Aug. 31 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Construction of a Predictive Model for Neoadjuvant Chemotherapy Response in Advanced High-Grade Serous Ovarian Cancer Based on Tumor-Infiltrating CD19⁺ B Cells: A National Multicenter Retrospective Validation Study'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600131064
Registration Time: 2026/08/28
Type: Observational study
Primary Sponsor: Fudan University Shanghai Cancer Center
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338364
Published by HT Digital Content Services with permission from Health Daily Digest....